Structures by: Maddaford A.

Total: 4

(palmitoyloxy) methyl 2-methyl-4-(4-methylpiperazin-1-yl)-4H-benzo[b]thieno[2,3-e][1,4]diazepine-5-carboxylate

C25H32N4O4S

Blumberg, Laura C.Zeidan, Tarek A.Maddaford, AdrianWarren, Nicole C.Hutchison, Panee

RSC Advances (2013) 3, 37 16270

a=10.5728(2)Å   b=14.8243(3)Å   c=16.8046(3)Å

α=90.00°   β=104.795(1)°   γ=90.00°

(butyryloxy) methyl 2-methyl-4-(4-methylpiperazin-1-yl)-4H-benzo[b]thieno[2,3-e][1,4]diazepine-5-carboxylate

C23H28N4O4S

Blumberg, Laura C.Zeidan, Tarek A.Maddaford, AdrianWarren, Nicole C.Hutchison, Panee

RSC Advances (2013) 3, 37 16270

a=9.6417(6)Å   b=15.1369(11)Å   c=16.1772(11)Å

α=90.00°   β=97.283(3)°   γ=90.00°

(hexanoyloxy) methyl 2-methyl-4-(4-methylpiperazin-1-yl)-5H-benzo[b]thieno[2,3-e][1,4]diazepine-5-\ carboxylate

C35H52N4O4S

Blumberg, Laura C.Zeidan, Tarek A.Maddaford, AdrianWarren, Nicole C.Hutchison, Panee

RSC Advances (2013) 3, 37 16270

a=14.4300(15)Å   b=14.9488(15)Å   c=16.2240(14)Å

α=90.00°   β=92.753(7)°   γ=90.00°

CSF93/Spivey/AN-Wafers/4999/12-3-99.

C23H24N2O2

Spivey, Alan C.Maddaford, AdrianFekner, TomaszRedgrave, Alison J.Frampton, Christopher S.

Journal of the Chemical Society, Perkin Transactions 1 (2000) 20 3460

a=5.3697(3)Å   b=16.3416(14)Å   c=21.7265(18)Å

α=90.00°   β=90.00°   γ=90.00°